INTRODUCTION
============

A single fertilized egg gives rise to all cell types in the human body. Despite carrying the same genetic information, every cell in our body is unique and shows substantial variability in cellular phenotype compared with other cells ([@b31-molce-42-3-189]; [@b90-molce-42-3-189]). A central challenge in biology is to understand how such cellular diversity is generated from a single cell, how it is regulated for tissue homeostasis, and how it is exploited for mounting appropriate responses to external perturbations in normal and diseased tissues. Answering these questions requires single-cell measurements of molecular and cellular features.

Over the past decade, single-cell RNA sequencing (scRNA-seq) technologies have been developed that provide an unbiased view of cell-to-cell variability in gene expression within a population of cells ([@b25-molce-42-3-189]; [@b61-molce-42-3-189]; [@b109-molce-42-3-189]; [@b121-molce-42-3-189]). Recent technological developments in both microfluidic and barcoding approaches allow the transcriptomes of tens of thousands of single cells to be assayed. Coupled with the exponential increase in the amount of single-cell transcriptomic data, computational tools necessary to achieve robust biological findings are being actively developed ([@b104-molce-42-3-189]; [@b124-molce-42-3-189]). In this review, we provide an overview of scRNA-seq protocols and existing computational methods for dissecting cellular heterogeneity from scRNA-seq data, and discuss their assumptions and limitations. We also examine potential future developments in the field of single-cell genomics.

TECHNOLOGIES OF SCRNA-SEQ
=========================

The first paper demonstrating the feasibility of profiling the transcriptomes of individual mouse blastomeres and oocytes captured by micromanipulation was published in 2009 ([@b110-molce-42-3-189])---1 year after the introduction of bulk RNA-seq ([@b69-molce-42-3-189]; [@b81-molce-42-3-189]; [@b82-molce-42-3-189]). The early protocols for scRNA-seq were applied only to a small number of cells and suffered from a high level of technical noise resulting from inefficient reverse transcription (RT) and amplification ([@b91-molce-42-3-189]; [@b95-molce-42-3-189]; [@b110-molce-42-3-189]). These limitations of early protocols have been mitigated by two innovative barcoding approaches.

Cellular and molecular barcoding
--------------------------------

The cell barcoding approach integrates a short cell barcode (CB) into cDNA at the early step of RT, first introduced in the single-cell tagged reverse transcription sequencing (STRT-seq) protocol ([@b48-molce-42-3-189]). All cDNAs from cells are pooled for multiplexing, and downstream steps are carried out in a single tube, reducing reagent and labor costs. The cell barcoding approach was adopted to increase the number of cells in a plate-based or droplet-based platform. Early protocols relied on the plate-based platform, in which each cell is sorted into individual wells of a microplate, such as a 96- or 384-well plate, using fluorescence-activated cell sorting (FACS) or micropipettes ([@b43-molce-42-3-189]; [@b48-molce-42-3-189]; [@b50-molce-42-3-189]). Each well contains well-specific barcoded RT primers ([@b43-molce-42-3-189]; [@b50-molce-42-3-189]) or barcoded oligonucleotides for template-switching PCR ([@b48-molce-42-3-189]), and subsequent steps after RT are performed on pooled samples. In the droplet-based platform, encapsulating single cells in a nano-liter emulsion droplet containing lysis buffer and beads coated with barcoded RT primers was found to markedly increase the number of cells to tens of thousands in a single run ([@b60-molce-42-3-189]; [@b76-molce-42-3-189]; [@b125-molce-42-3-189]).

The molecular barcoding approach for reducing amplification bias in PCR or in vitro transcription introduces a randomly synthesized oligonucleotide known as a unique molecular identifier (UMI) into RT primers ([@b49-molce-42-3-189]). During RT, each cDNA is labeled with a UMI; thus, the number of cDNAs of a gene before amplification can be inferred by counting the number of distinct UMIs mapped to the gene, eliminating amplification bias.

Further improvements for sensitivity and throughput
---------------------------------------------------

These two barcoding strategies have become the standard in recently developed methods for scRNA-seq, which had already been improved compared with early protocols in terms of sensitivity and throughput. For most protocols, the sensitivity of recovering mRNA molecules present in a single cell is \~3--20% ([@b83-molce-42-3-189]). Inefficient RT is responsible for such low capture rates; therefore, considerable effort has been devoted to increasing cDNA yield through optimization of RT enzymes ([@b42-molce-42-3-189]), buffer conditions ([@b88-molce-42-3-189]; [@b94-molce-42-3-189]), primers ([@b42-molce-42-3-189]; [@b88-molce-42-3-189]; [@b94-molce-42-3-189]), the subsequent amplification step ([@b9-molce-42-3-189]; [@b88-molce-42-3-189]), and reaction volume ([@b42-molce-42-3-189]). The most effective approach for improving sensitivity is to reduce the effective reaction volume, either by implementing nanoliter reactors in a microfluidics device ([@b42-molce-42-3-189]) or adding macromolecular crowding agents ([@b9-molce-42-3-189]). For example, the molecular crowding single-cell RNA bar-coding and sequencing (mcSCRB-seq) protocol achieved 2.5-fold increase in sensitivity compared with its previous version by combining macromolecular crowding and optimized amplification ([@b9-molce-42-3-189]).

Increasing the number of cells to be profiled is essential for the unbiased characterization of cellular heterogeneity within a population of cells. Two different approaches have been developed to improve cell throughput in plate-based methods. In the first approach, instead of sorting each cell into an individual well of a microplate by FACS or manual picking, a cell suspension is randomly loaded into an array of \~100,000 microwells that accommodate one cell and one bead coated with barcoded RT primers ([@b35-molce-42-3-189]; [@b41-molce-42-3-189]), increasing throughput in each experiment to tens of thousands of cells. In contrast to these approaches, which increase the number of wells in a microplate, a new approach was developed based on combinatorial cell barcoding ([@b22-molce-42-3-189]; [@b93-molce-42-3-189]). In this technique, a suspension of cells passes through multiple rounds of split-pool barcoding in 96- or 384-well plates containing well-specific barcodes. In each round, fixed cells or nuclei are randomly loaded into individual wells and tagged with well-specific barcodes through RT, ligation, or amplification. The split-pool barcoding approach does not require a special device for making droplets or microwells, and can multiplex multiple samples in a single experiment by loading each sample into different subsets of wells at the first round of combinatorial cell barcoding. However, this approach can only be applied to permeabilized fixed cells or nuclei. For droplet-based methods, there is no upper limit on the number of cells that can be captured, at least in theory, but typically 1,000--10,000 cells are captured in one run reducing the probability of capturing two or more cells in a droplet (called "doublets"). If multiple samples labeled with unique molecular features are pooled and doublets are demultiplexed according to their molecular features, the throughput of cells can be increased, facilitating concurrent processing of multiple samples in a single experiment and minimizing technical batch effects of droplet-based methods. Several molecular features have been developed for demultiplexing doublets, including natural genetic variation of individuals ([@b53-molce-42-3-189]) and lipid-modified oligonucleotides targeted to the plasma membrane ([@b79-molce-42-3-189]).

Integration
-----------

To define the detailed molecular state of cells, we need to measure multiple molecular readouts and their interplay from the same single cell. Since the type and state of cells are usually defined by the cells' transcriptomes, and the protocols for profiling the single-cell transcriptome of polyadenylated mRNAs are the most developed among single-cell omics technologies, considerable effort has been applied to combining the single-cell transcriptome with other molecular readouts in the same single cell ([@b23-molce-42-3-189]). Several methods that simultaneously profile genomic DNA and mRNA from the same single cell, including DNA-RNA sequencing (DR-seq) ([@b28-molce-42-3-189]) and genome and transcriptome sequencing (G&T-seq)([@b75-molce-42-3-189]), have been developed for linking genomic variation with transcriptomic heterogeneity. DNA methylation ([@b7-molce-42-3-189]; [@b45-molce-42-3-189]) has also been integrated with the transcriptome to reveal the interplay between the epigenome and transcriptome at single-cell resolution. Recent single-cell multiomics methods have combined more than two genomic and epigenomic layers with the transcriptome. For example, single-cell triple-omics sequencing (scTrio-seq) profiles genomic copy number variation, DNA methylation, and the transcriptome of a single cell ([@b44-molce-42-3-189]). Another method, scNMT-seq, combines the two epigenomic features of DNA methylation and chromatin accessibility with the transcriptome of a single cell ([@b26-molce-42-3-189]). Single-cell multiomics technologies have not been applied to a large number of cells, because they require manually separating the transcriptome library from the genome or epigenome library. A recent method based on the split-pool barcoding approach integrated the transcriptome with chromatin accessibility in thousands of single cells, demonstrating the feasibility of high-throughput single-cell multiomics technologies ([@b21-molce-42-3-189]).

The technologies for single-cell proteomics are still in their infancy because the methods for shotgun proteomics, such as liquid chromatography and tandem mass spectrometry (LC-MS/MS), require a large amount of input material and it is not possible to amplify proteins ([@b10-molce-42-3-189]; [@b15-molce-42-3-189]). Most protocols for single-cell protein quantification use high-affinity antibodies to measure the expression levels of a small number of targeted proteins. These antibodies are usually conjugated with fluorophores for flow cytometry ([@b85-molce-42-3-189]), metal isotopes for mass cytometry ([@b103-molce-42-3-189]), or DNA barcode sequences for quantitative PCR or sequencing ([@b115-molce-42-3-189]). The idea of using DNA barcode-conjugated antibodies has been extended to develop methods for jointly profiling the transcriptome and expression levels of targeted cell surface proteins in single cells ([@b86-molce-42-3-189]; [@b105-molce-42-3-189]).

COMPUTATIONAL ANALYSIS OF SCRNA-SEQ DATA
========================================

As scRNA-seq has become a well-established method for dissecting cellular heterogeneity in complex tissues, the associated computational tools necessary for analyzing single-cell transcriptomic data continue to be designed and developed. As of November 2018, 325 tools have been deposited at the scRNA-tools database ([www.scRNA-tools.org](www.scRNA-tools.org)), and the number of tools being added is growing exponentially ([@b124-molce-42-3-189]). Compared with the analysis of bulk RNA-seq, scRNA-seq data analysis has several unique features. First, the gene-by-cell count matrix is very sparse owing to inefficient capture rates of mRNA molecules and low sequencing depth per cell, which results in higher technical variability in gene expression across cells. Second, tens of thousands of single cells are analyzed in a typical single-cell experiment, whereas the number of samples in bulk RNA-seq is usually three per condition, highlighting the importance of computational efficiency in tools for analyzing scRNA-seq data. Third, since the type and state of each cell are generally unknown, the expectation is that such information will be inferred from scRNA-seq data through unsupervised analysis, such as visualization and cell type identification. However, for bulk RNA-seq data, in which the class label of each sample is known a priori, genes that are differentially expressed between classes are usually identified through supervised analysis and hypothesis testing. Finally, there are single-cell--specific biological questions that cannot be addressed by bulk-level analysis. For example, it is possible to infer how individual tissue stem cells differentiate into multiple lineages during tissue homeostasis by estimating the ordering of cells along differentiation trajectories from a mixture of cells with heterogeneous differentiation states. The workflow of scRNA-seq data analysis includes four steps: data generation, data preprocessing, exploratory analysis, and heterogeneity analysis ([Fig. 1](#f1-molce-42-3-189){ref-type="fig"}).

Data generation: generating a count matrix
------------------------------------------

The basic pipeline for generating a gene-by-cell count matrix from high-throughput scRNA-seq data consists of four common steps: barcode processing, read mapping, gene counting, and cell filtering. Several tools have been developed for this purpose, including Cell Ranger ([@b125-molce-42-3-189]), UMI-tools ([@b101-molce-42-3-189]), umis ([@b107-molce-42-3-189]), ESAT ([@b27-molce-42-3-189]), dropEst ([@b87-molce-42-3-189]), scPipe ([@b112-molce-42-3-189]) and zUMIs ([@b84-molce-42-3-189]). In the first step (barcode processing), we reformat each read pair in paired-end FASTQ files by trimming the CB and UMI from one read and adding this information to the sequence identifier line of the other read in the pair. Sequencing errors introduced into CBs and UMIs can optionally be corrected by filtering out read pairs with low-quality CBs and UMIs according to Phred quality scores. The reformatted reads are then mapped to the genome or transcriptome using any of the popular aligners developed for bulk RNA-seq data. Exon mapped reads from output BAM files are assigned to genes by a gene annotation GTF file and demultiplexed by CBs. For single-nuclei RNA-seq data, in which precursor mRNAs are abundant, both exon and intron mapped reads can be considered in gene counting to improve the number of detected genes ([@b84-molce-42-3-189]). PCR duplicates are removed by collapsing reads that are assigned to the same gene and share an identical UMI. Optionally, both sequencing and amplification errors in UMI sequences can be accounted for by collapsing UMIs if their edit distance is small and one UMI has a much higher read count than others. UMI-tools ([@b101-molce-42-3-189]) uses a more elaborate method for UMI collapsing. It constructs UMI networks in which each node is labeled with a UMI sequence and read count, and two nodes are connected if their edit distance is 1. UMI collapsing is done by detecting modules in UMI networks based on adjacency and read counts.

After demultiplexing CBs and collapsing UMIs, a raw count matrix is obtained in which only a subset of CBs corresponds to intact cells. In plate-based protocols, CBs for intact cells can easily be identified and sequence errors in CBs can be corrected by comparing them with a list of known well-specific CBs. In droplet-based protocols, multiple heuristic methods have been proposed for filtering out CBs that correspond to empty droplets. The most popular method is to detect the threshold at the "knee point" in the barcode rank plot, where all cell barcodes are sorted by the total UMI counts in descending order. All CBs with a total UMI count less than the threshold are considered empty droplets and discarded ([@b76-molce-42-3-189]; [@b126-molce-42-3-189]). Empty droplets contain cell-free transcripts in the cell suspension, which is the major source of non-zero total UMI counts for these CBs. A recent method has proposed a statistical framework for testing whether a CB is significantly different from cell-free transcript profiles, and combined this testing framework with the knee point method ([@b71-molce-42-3-189]). This approach is implemented in DropletUtils ([@b71-molce-42-3-189]) and Cell Ranger 3.0. If the expected number of cells is known, CBs can be discarded using a manually set threshold, and CBs corresponding to low-quality cells can be further filtered out based on multiple cell-level quality control (QC) metrics ([@b112-molce-42-3-189]).

It is essential to discard low-quality cells, such as damaged or dying cells to avoid unwanted variation and misleading results in downstream analyses driven by these cells ([@b47-molce-42-3-189]). Two types of cell-level QC features are widely used to distinguish low- from high-quality cells ([@b47-molce-42-3-189]): (1) technical features that are proportional to total mRNA content, such as total UMI count, number of detected genes and proportion of reads mapped to spike-ins; and (2) biological features related with cell death or cell rupture, such as the proportion of reads that map to mitochondrial DNA. Although some methods use machine learning classifiers to automatically detect low-quality cells ([@b47-molce-42-3-189]; [@b87-molce-42-3-189]), the characteristics of low-quality cells are data-specific. Therefore, it is still recommended to visually inspect outliers corresponding to low-quality cells, with the aid of multiple diagnostic plots of cell-level QC metrics. Several tools, including scater ([@b78-molce-42-3-189]) and scPipe ([@b112-molce-42-3-189]), are available for computing QC metrics and visualizing them in diagnostic plots.

Data preprocessing: normalization, imputation, and feature selection
--------------------------------------------------------------------

The next step is to estimate the true expression level of each gene in each cell by removing cell-specific biases in the gene-by-cell count matrix. The assumption in this analysis is that the expected count of a gene in a cell is proportional to the product of the relative expression level of the gene and the cell-specific global scaling factor. The global scaling factor represents cell-specific systematic biases affected by cell-to-cell differences in cell size, capture and RT efficiency, amplification factor, dilution factor, and sequencing depth ([@b117-molce-42-3-189]). Cell-specific biases can be removed by normalizing the raw counts within each cell by a single scaling factor, applied to all genes in a cell. The cell-specific scaling factor can be estimated based on library size (e.g., reads per million (RPM) or transcripts per kilobase million (TPM)([@b66-molce-42-3-189])), upper quantile values of counts ([@b16-molce-42-3-189]), or normalization factors (e.g., size factor of DESeq ([@b5-molce-42-3-189]) or trimmed mean of M-value of edgeR ([@b92-molce-42-3-189])), developed for bulk RNA-seq normalization. However, normalization by library size is sensitive to a few highly expressed genes, and the other normalization methods are problematic for sparse scRNA-seq data, since estimated scaling factors are unstable and inaccurate owing to zero inflation ([@b117-molce-42-3-189]). Several normalization methods have been proposed for robustly estimating the cell-specific scaling factors in the presence of excessive zero counts ([@b72-molce-42-3-189]; [@b116-molce-42-3-189]). For example, scran estimates pooled size factors from a pool of cells by summing expression values across these cells and then deconvolves the pooled size factors obtained from multiple pools to their cell-specific size factors ([@b72-molce-42-3-189]).

A high frequency of zero counts, which is driven by stochastic gene expression ([@b57-molce-42-3-189]), low mRNA capture efficiency and low sequencing depth, is a key characteristic of high-throughput scRNA-seq data. This zero inflation leads to high technical variability in gene expression, an effect that should be carefully accounted for in downstream analyses requiring accurate measurements of gene expression. Because global scaling normalization methods are unable to address this issue, computational approaches that recover the true expression levels of zero counts have been proposed ([@b24-molce-42-3-189]; [@b46-molce-42-3-189]; [@b68-molce-42-3-189]; [@b119-molce-42-3-189]). These imputation methods take a normalized count matrix (usually log-transformed) as input and replace input data with de-noised values, estimated by borrowing information across similar cells ([@b24-molce-42-3-189]; [@b68-molce-42-3-189]; [@b119-molce-42-3-189]) or genes ([@b46-molce-42-3-189]). These imputed expression values can be used to recover regulatory interactions between genes ([@b46-molce-42-3-189]; [@b119-molce-42-3-189]), increase the accuracy of estimates of cell-to-cell variability in gene expression ([@b46-molce-42-3-189]), and improve cell clustering and differential gene expression analysis ([@b24-molce-42-3-189]; [@b46-molce-42-3-189]; [@b68-molce-42-3-189]). However, despite the potential of these imputation methods to recover true expression levels, it should be noted that all such methods introduce unexpected biases, including spurious gene-to-gene correlations, artificial cell subpopulation structure, and removal of rare cell types and transient cell states. Because these biases have not been rigorously examined, imputation should be applied with caution and is not included in the general workflow for scRNA-seq data analysis.

The normalized count matrix contains many genes whose expression levels are associated with a high level of technical noise. These genes mask the reliable detection of different cell types and states within a heterogeneous population of cells. It is necessary to filter out such genes to improve the extraction of biologically interesting patterns in the scRNA-seq data, a process known as feature selection. The most widely used approach is to evaluate the biological cell-to-cell variability in the expression of each gene, and then take genes showing significantly high biological variability as input in downstream unsupervised analyses such as visualization and clustering ([@b13-molce-42-3-189]; [@b73-molce-42-3-189]; [@b116-molce-42-3-189]). The key idea in evaluating biological variability is to decompose the observed variance of gene expression levels into its technical and biological components according to the law of total variance. To estimate the technical variability, we assume that the mean technical variance of each gene is a nonlinear function of its mean expression level. The nonlinear function can be estimated by fitting a curve to the mean-variance data of external RNA spike-ins ([@b13-molce-42-3-189]; [@b56-molce-42-3-189]; [@b116-molce-42-3-189]) or all endogenous genes, under the assumption that the observed variance of most genes is dominated by technical noise ([@b62-molce-42-3-189]; [@b73-molce-42-3-189]). By subtracting the estimated technical variance from the observed variance, we can estimate the biological variance and choose highly variable genes that show significant non-zero biological variance.

Exploratory analysis: dimensionality reduction
----------------------------------------------

By selecting informative genes, such as highly variable genes, the dimension of scRNA-seq data is reduced to the number of chosen genes, but the results still suffer from high dimensionality, which makes it difficult to comprehend and visualize the patterns of cellular heterogeneity. Dimensionality reduction is performed to find a low-dimensional representation that preserves the relevant structure of the original high-dimensional data. In the context of scRNA-seq data analyses, two different relevant structures are considered: a local structure that preserves cell-to-cell distance within a local neighborhood of cells, and a global structure that preserves cell-to-cell distance on the low-dimensional manifold associated with the underlying biological process. Capturing local structure in a low-dimensional representation is important for clustering cells of the same type or state close together. In contrast, capturing global structure is useful for preserving distance between clusters and revealing underlying biological processes for cell-to-cell variability in gene expression. Principal component analysis (PCA), a linear method used for dimensionality reduction, projects high-dimensional data onto a low-dimensional linear space by maximizing the variance of the projected data. PCA is also a popular method for data pre-processing since it removes redundancies among genes owing to its orthogonal linear projection. Many dimensionality reduction methods use PCA as a preprocessing step to reduce distortions incurred because of irrelevant dimensions in the calculation of pairwise distances between cells.

Although PCA has been successfully applied to capture the global structure of cellular heterogeneity in low-throughput scRNA-seq data ([@b13-molce-42-3-189]; [@b43-molce-42-3-189]; [@b88-molce-42-3-189]; [@b99-molce-42-3-189]), it is limited by its frequent failure to visualize the local structure essential for cell clustering and cell type identification. This issue was addressed by introducing t-distributed stochastic neighbor embedding (t-SNE) ([@b118-molce-42-3-189]) to the field of single-cell genomics ([@b4-molce-42-3-189]). t-SNE is a nonlinear dimensionality reduction method for capturing the local structure in which dissimilar cells in the original high-dimensional space are modeled by large distances, and similar cells are modeled by small distances. Thus, t-SNE generates a low-dimensional representation in a two- or three-dimensional space displaying multiple isolated clusters. However, global structures, such as the distance between clusters, are not well captured in the t-SNE map. The current state-of-the-art method for dimensionality reduction that captures both local and global structure in scRNA-seq data is uniform manifold approximation and projection (UMAP) ([@b11-molce-42-3-189]; [@b80-molce-42-3-189]). It has been shown that UMAP is able to arrange clusters along differentiation trajectories and preserve a differentiation continuum of transient cells ([@b11-molce-42-3-189]). Understanding the captured local and global structure in the low-dimensional representation can be facilitated by overlaying the expression of a marker gene or the activity of a set of genes associated with a biological process of interest on the two- or three-dimensional map, a step that is useful for exploratory data analysis.

Heterogeneity analysis: clustering and trajectory inference
-----------------------------------------------------------

Two computational approaches for dissecting cellular heterogeneity in scRNA-seq data have been developed based on the assumption that a latent variable generates the observed cell-to-cell variability: 1) a discrete latent variable approach that labels each cell with a discrete cluster indicator for cell type or state, and 2) a continuous latent variable approach that labels each cell with a continuous pseudotime for differentiation trajectories The correct reference is ([@b121-molce-42-3-189]).

The discrete latent variable approach can be formulated as an unsupervised clustering problem which has been extensively studied in the field of statistics and machine learning. Diverse clustering algorithms, such as k-means, hierarchical, density-based, and graph-based clustering, have been applied to identify cell clusters in scRNA-seq data ([@b6-molce-42-3-189]; [@b58-molce-42-3-189]; [@b96-molce-42-3-189]). A number of considerations should be taken into account to ensure that each cluster is associated with a distinct cell type or state. First, selecting genes showing differential expression across multiple cell types is essential for improving the quality of clustering results. Such relevant genes can be identified by selecting genes that are highly variable across cells. Both feature selection and dimensionality reduction (e.g., PCA and t-SNE) can be sequentially applied to extract informative features that are taken as input to clustering algorithms ([@b6-molce-42-3-189]; [@b30-molce-42-3-189]). Second, because the optimal number of clusters is dependent on the definition of cell types or states and subjective clustering resolution, it cannot be generally estimated from data. It is generally recommended that the number of clusters should be chosen by a user with domain-specific knowledge. Third, identifying rare cell types, such as stem cells and short-lived progenitors, in a heterogeneous population requires careful examination of outliers within a large cluster ([@b36-molce-42-3-189]) or selection of genes that are specifically expressed in a minor population of cells as features ([@b52-molce-42-3-189]). Fourth, if samples are processed in multiple batches and technical batch effects largely account for the observed variability, batch effects should be adjusted while preserving global structure. If the biological condition is not confounded by batch information, regression-based batch correction methods originally designed for bulk RNA-seq can be applied ([@b18-molce-42-3-189]; [@b62-molce-42-3-189]). However, in a confounded design, which is common in the droplet-based protocols, the batch correction methods regress out both biological and technical variability. One solution is to project the expression profile of each cell to a feature space by calculating the correlation coefficient between the expression vector of single cells and the expression vector of the reference bulk panel of diverse cell types ([@b67-molce-42-3-189]). Although this approach improves clustering accuracy in the presence of batch effects, obtaining a reference panel that contains all cell types of single cells is not straightforward. A more general strategy is to merge multiple scRNA-seq data with shared subpopulations using canonical correlation analysis ([@b17-molce-42-3-189]) or by identifying mutual nearest neighbors ([@b40-molce-42-3-189]).

Finally, the identified clusters are annotated as cell types or states using the expression of known marker genes. To automate this annotation, researchers have developed correlation-based scoring methods ([@b8-molce-42-3-189]; [@b59-molce-42-3-189]) or machine learning classifiers ([@b2-molce-42-3-189]; [@b3-molce-42-3-189]) with the aid of reference bulk transcriptomes ([@b8-molce-42-3-189]) or reference single-cell transcriptomes ([@b2-molce-42-3-189]; [@b3-molce-42-3-189]; [@b59-molce-42-3-189]). The identity of cell clusters can also be inferred by examining differentially expressed genes across cell clusters and their enriched functional categories of genes. Although statistical methods designed for differential expression analysis in scRNA-seq have been developed ([@b33-molce-42-3-189]; [@b55-molce-42-3-189]), their performance is comparable or sometimes inferior to methods designed for bulk RNA-seq or general purpose two-sample tests, such as the t-test and Wilcoxon rank sum test ([@b102-molce-42-3-189]).

The continuous latent variable approach, pioneered by Monocle ([@b113-molce-42-3-189]), is referred to as trajectory inference or pseudotemporal ordering. The main assumption underlying this approach is that there exists a dynamic cellular process that shapes the transcriptional landscape and each individual cell can be placed along the process. Many dynamic cellular processes, including differentiation ([@b120-molce-42-3-189]), reprogramming ([@b114-molce-42-3-189]), and cell cycling ([@b63-molce-42-3-189]), continuously progress along single or multiple trajectories, passing through transient cell states. The temporal progression of each cell along these trajectories, termed pseudotime, is the continuous latent variable that is inferred from data. If a large number of cells covering transient states are sampled from a mixed population of cells whose cell-to-cell variability is largely driven by a given cellular process, trajectories can be accurately reconstructed. Over the last 4 years, more than 60 computational tools have been developed for pseudotemporal ordering ([@b124-molce-42-3-189]). Most of these tools operate based on the assumption that cells showing similar expression profiles should be placed close together on the same trajectories ([@b54-molce-42-3-189]). They use a recurring framework that consists of two steps: 1) constructing a low-dimensional representation of cells, and 2) modeling trajectories with graphs or curves in the low-dimensional representation ([@b20-molce-42-3-189]).

In the first step, two different classes of representation are used: (1) a two- or three-dimensional feature space generated using dimensionality reduction algorithms, and (2) a k-nearest neighbor graph (k-NNG) in which each cell is represented as a node and each node is linked with its k nearest neighbors. The low-dimensional feature space can be constructed by applying diverse dimensionality reduction algorithms, including PCA ([@b100-molce-42-3-189]), independent component analysis ([@b113-molce-42-3-189]), t-SNE ([@b77-molce-42-3-189]), diffusion map ([@b39-molce-42-3-189]), or UMAP ([@b11-molce-42-3-189]), after selecting genes relevant to the cellular process of interest. In principle, algorithms that preserve the global structure in the low-dimensional feature space, such as diffusion map and UMAP, should be used. The k-NNG is usually constructed after projecting cells to the low-dimensional feature space using dimensionality reduction methods ([@b12-molce-42-3-189]; [@b98-molce-42-3-189]). For better visualization, k-NNGs can be arranged in a two-dimensional space using the force-directed layout embedding ([@b14-molce-42-3-189]; [@b97-molce-42-3-189]). For feature selection, there is no consensus on the best practice for selecting genes that are informative with respect to constructing the low-dimensional representation. Widely used criteria for this process include highly expressed genes, highly variable genes across cells, differentially expressed genes across cell clusters ([@b89-molce-42-3-189]; [@b113-molce-42-3-189]), genes that show gradual changes within a local neighborhood ([@b122-molce-42-3-189]), and a set of known genes related to the cellular process.

In the second step of modeling trajectories, a backbone of trajectories is constructed with graphs or curves in the low-dimensional representation, and then the pseudotime of cells is evaluated by projecting cells onto the backbone. Constructing the backbone, which usually requires prior information, such as the structure of trajectories and a root cell with a pseudotime of 0, is the key step for determining the accuracy of inferred trajectories. Early methods fixed the structure of trajectories as linear([@b12-molce-42-3-189]; [@b100-molce-42-3-189]) or bifurcating ([@b39-molce-42-3-189]; [@b98-molce-42-3-189]). A more complex structure of trajectories is difficult to correctly reconstruct from data, since it becomes more sensitive to outlier cells, requires more prior information, and needs sampling of a sufficient number of cells. The most widely used strategy for addressing this issue is to group cells into clusters that represent distinct cell types or states. The backbone is constructed by linking clusters, and the trajectories are inferred by specifying the start clusters ([@b106-molce-42-3-189]), both start and end clusters ([@b70-molce-42-3-189]), or all clusters on a given trajectory ([@b123-molce-42-3-189]). Several methods for identifying the least differentiated cells (or stem cells) have been proposed for facilitating construction of the backbone ([@b37-molce-42-3-189]; [@b111-molce-42-3-189]). In addition, the direction and the speed of differentiation can be inferred from RNA velocity, but this is sensitive to the set of input genes ([@b64-molce-42-3-189]). After reconstructing trajectories, the dynamics of gene regulation along the inferred trajectories can be analyzed ([@b1-molce-42-3-189]).

FUTURE DEVELOPMENTS
===================

Over the past decade, technologies for single-cell transcriptomics have emerged as essential tools for dissecting cellular heterogeneity in individual tissues. Rapid technological advances are expected to expand the breadth and depth of the application of scRNA-seq. Comprehensive transcriptomic reference maps of all cell types in the body of diverse organisms, including humans ([@b74-molce-42-3-189]) and mice ([@b41-molce-42-3-189]; [@b108-molce-42-3-189]), are being constructed to provide a systematic framework for understanding the molecular characteristics of cell types or states, cellular trajectories and molecular mechanisms of development and differentiation, and regulatory interactions between cells. A more in-depth single-cell transcriptomic analysis that profiles non-mRNA species, such as microRNAs ([@b32-molce-42-3-189]) or full-length mRNA isoforms ([@b38-molce-42-3-189]), within a single cell is also being actively developed. Integrating the transcriptome with multiple omics ([@b23-molce-42-3-189]), genotypes ([@b29-molce-42-3-189]; [@b51-molce-42-3-189]), cellular phenotypes ([@b19-molce-42-3-189]; [@b34-molce-42-3-189]), lineage tracing ([@b54-molce-42-3-189]), and spatial information ([@b65-molce-42-3-189]) within the same cell is another active area of ongoing research. In parallel with technological advances, computational methods that integrate diverse molecular and cellular information from the same cell and infer hidden biological structures from large-scale single-cell data should be developed.
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